The pilot aims to deliver the first wave 1 regulatory assessment in 14 calendar days for qualifying applications by the end of 2026.
UK MHRA · August 17, 2026
Guidance: Clinical trials: Phase 1, 14-Day Pilot Programme
MHRA pilot programme to deliver first-wave regulatory assessment of qualifying Phase 1 applications within 14 calendar days by end of 2026.
Regulatory Deadline
December 31, 2026
Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.